Merck ( MRK, Financials) stated that sacituzumab tirumotecan (sac-TMT) was designated a Breakthrough Therapy by the FDA for advanced or metastatic nonsquamous non-small cell lung cancer with epidermal ...

Copyright ©2024. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Manage cookie preferences ...

近日，病毒学国家重点实验室付碧石研究组在国际学术期刊Autophagy上在线发表题为“AP3B1 facilitates PDIA3/ERP57 function to regulate rabies virus glycoprotein ...

Final data demonstrate CM24 in combination with nivolumab and Nal-IRI/5FU/LV chemotherapy clear and consistent improvement ...

From luxe holiday picks to stocking-friendly favorites, discover the perfect presents for every beauty lover on your list.

BestReviews rounded up the top Cyber Monday beauty deals of 2024 on makeup, skin care and hair care products that you can ...

Purple Biotech (PPBT) reported final results from the randomized Phase 2 study of its lead oncology drug, CM24, a humanized monoclonal antibody ...

Uncover substantial savings and top discounts on premium skincare products, helping you enhance your beauty routine without ...

Shares of Purple Biotech ($PPBT) surged more than 45% on Monday morning, reaching their highest levels since early October.

The following is a summary of “Cerebral cortical encephalitis in adults with myelin oligodendrocyte glycoprotein antibody-associated disease: A national case series,” published in the November 2024 ...

GSK has received approval from Japan's MHLW for its application to extend the indication of its RSV vaccine, Arexvy.